Selective oral decontamination in cystic fibrosis: an attempt to prevent pseudomonas colonisation.
Dalzell
A M
AM
Royal Liverpool Children's Hospital Alder Hey, UK.
van Saene
H K
HK
Heaf
D P
DP
D000284:Administration, Oral; D000293:Adolescent; D000900:Anti-Bacterial Agents; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000382:microbiology; D004359:Drug Therapy, Combination / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009960:Oropharynx / Q000187:drug effects / Q000382:microbiology; D011552:Pseudomonas Infections / Q000517:prevention & control; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification
D000900:Anti-Bacterial Agents